Hua Xiang Selected Research

Hua Xiang Research Topics

Disease

39	Neoplasms (Cancer) 04/2024 - 01/2005
23	Breast Neoplasms (Breast Cancer) 12/2023 - 09/2009
16	Infections 01/2023 - 02/2005
10	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2015
4	Inflammation (Inflammations) 10/2023 - 12/2012
4	Hemorrhage 10/2023 - 09/2020
4	Pneumonia (Pneumonitis) 01/2022 - 01/2019
4	Leukemia 08/2020 - 01/2018
4	Fever (Fevers) 01/2020 - 02/2005
3	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 10/2019
3	Diarrhea 08/2021 - 12/2006
3	Triple Negative Breast Neoplasms 01/2021 - 09/2018
3	Pain (Aches) 01/2020 - 01/2018
3	Asthma (Bronchial Asthma) 11/2013 - 09/2005
2	Wounds and Injuries (Trauma) 01/2023 - 01/2020
2	Pseudorabies 01/2023 - 12/2009
2	Fatigue 08/2021 - 08/2021
2	Hyperlipidemias (Hyperlipidemia) 05/2021 - 01/2018
2	Stomach Neoplasms (Stomach Cancer) 11/2020 - 04/2012
2	Dehydration (Water Stress) 01/2020 - 04/2016
2	Jaundice (Icterus) 01/2018 - 10/2016
2	Lymphoma (Lymphomas) 01/2018 - 11/2012
2	Liver Failure 10/2016 - 02/2012
2	Body Weight (Weight, Body) 03/2015 - 05/2010
2	Autolysis 10/2011 - 01/2011
2	Weight Loss (Weight Reduction) 05/2011 - 05/2010
2	Hemolysis 02/2011 - 09/2010
1	Pathologic Processes 02/2024
1	Heart Diseases (Heart Disease) 10/2023
1	Virus Diseases (Viral Diseases) 10/2023
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2023
1	Hemophilia A (Haemophilia) 05/2023
1	Portal Hypertension 02/2023

Drug/Important Bio-Agent (IBA)

10	Estrogen ReceptorsIBA 12/2023 - 05/2014
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2005
8	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 03/2010
6	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2019 - 05/2014
6	Selective Estrogen Receptor Modulators (SERM)IBA 01/2019 - 09/2009
5	EnzymesIBA 01/2023 - 01/2014
5	Tamoxifen FDA LinkGeneric 01/2019 - 09/2009
4	Messenger RNA (mRNA)IBA 01/2023 - 01/2005
3	Estrogen Receptor alphaIBA 04/2024 - 10/2021
3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023 - 01/2018
3	VaccinesIBA 01/2023 - 08/2005
3	Hemolysin Proteins (Hemolysins)IBA 01/2022 - 03/2010
3	LipidsIBA 01/2021 - 05/2010
3	Antineoplastic Agents (Antineoplastics)IBA 12/2020 - 01/2019
3	NucleotidesIBA 10/2019 - 02/2005
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2014 - 06/2010
3	AntigensIBA 01/2014 - 08/2005
2	snake venom protein C activatorIBA 04/2024 - 11/2020
2	Androgen Receptors (Androgen Receptor)IBA 03/2024 - 12/2022
2	MicroRNAs (MicroRNA)IBA 10/2023 - 11/2020
2	Histone Deacetylase InhibitorsIBA 01/2023 - 12/2021
2	Antiviral Agents (Antivirals)IBA 01/2023 - 05/2009
2	AndrogensIBA 12/2022 - 10/2019
2	Coloring Agents (Dyes)IBA 01/2022 - 09/2010
2	Sorafenib (BAY 43-9006)FDA Link 08/2021 - 08/2021
2	Alanine Transaminase (SGPT)IBA 08/2021 - 08/2021
2	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 03/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 06/2017
2	LigandsIBA 04/2018 - 11/2017
2	Raloxifene Hydrochloride (Evista)FDA Link 01/2018 - 09/2009
2	ParaffinIBA 08/2016 - 01/2005
2	Virulence Factors (Pathogenicity Factors)IBA 08/2015 - 06/2010
2	CytokinesIBA 08/2015 - 11/2013
2	Recombinant ProteinsIBA 03/2015 - 01/2014
2	Therapeutic UsesIBA 01/2015 - 12/2012
2	DNA (Deoxyribonucleic Acid)IBA 08/2014 - 01/2011
2	Hormones (Hormone)IBA 08/2014 - 09/2009
2	Docetaxel (Taxotere)FDA Link 01/2014 - 01/2013
2	OvalbuminIBA 11/2013 - 12/2011
2	Enterotoxins (Enterotoxin)IBA 06/2010 - 03/2010
2	Fatty Acids (Saturated Fatty Acids)IBA 05/2010 - 05/2010
2	EstersIBA 05/2010 - 05/2010
2	IsoflavonesIBA 05/2010 - 05/2010
1	Focal Adhesion Protein-Tyrosine KinasesIBA 04/2024
1	Transcription Factors (Transcription Factor)IBA 04/2024
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2024
1	Reactive Nitrogen SpeciesIBA 02/2024
1	Peroxynitrous Acid (Peroxynitrite)IBA 02/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024
1	AnionsIBA 02/2024
1	CoagulantsIBA 10/2023
1	SaltsIBA 10/2023
1	emicizumabIBA 05/2023
1	naringeninIBA 01/2023
1	chrysinIBA 01/2023
1	pseudorabies virus glycoprotein DIBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023

Therapy/Procedure

23	Therapeutics 04/2024 - 02/2012
5	Microspheres (Microsphere) 03/2021 - 01/2019
4	Drug Therapy (Chemotherapy) 01/2019 - 01/2013
2	First Aid (Aids, First) 02/2023 - 11/2020
2	Emergency Treatment 02/2023 - 11/2020
2	Aftercare (After-Treatment) 01/2019 - 04/2018
1	Punctures 10/2023
1	Contraindications 02/2023
1	Resuscitation 01/2023
1	Castration 12/2022